Question

A 46-year-old man with 2 weeks of polyuria and polydipsia has an A1c of 10.5% and established ASCVD. Which initial pharmacotherapy is prioritized to reduce cardiovascular events?

Accepted Answer

SGLT2 inhibitor or GLP-1 receptor agonist with proven CV benefit

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

Answer

Basal insulin only

Practice question

A 46-year-old man with 2 weeks of polyuria and polydipsia has an A1c of 10.5% and established ASCVD. Which initial pharmacotherapy is prioritized to reduce cardiovascular events?